Mycapssa is indicated for long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide
Settlers Corporate Campus
Building Five
121 Bayer Road
Pittsburgh, PA 15205
Phone: 855.726.8479
(412.246.9858)
Fax: 855.246.3986
(412.787.9400)
Email: pharmacist@pantherxrare.com
Who We Serve
Patients
Manufacturers
Prescribers
Payers
Resources
Patients
Medications
Careers
Contact Us
Copyright © 2025 PANTHERx Specialty LLC. All rights reserved. PANTHERx RARE PHARMACY, “REINVENTING PHARMACY, REVOLUTIONIZING SPECIALTY, REDEFINING CARE”, and THE RARE DISEASE SP are registered service marks of PANTHERx Specialty LLC.
